|
|
Described are nucleic acid molecules encoding polypeptides having the
enzymatic activity of an RNA-directed RNA polymerase (RdRP). Vectors
comprising said nucleic acid molecules, wherein the nucleic acid
molecules are operatively linked to regulatory elements allowing
expression In prokaryotic and/or eukaryotic host cells are provided.
Additionally, polypeptides encoded by said nucleic acid molecules and
methods for the production of said polypeptides are described. Described
are also pharmaceutical and diagnostic compositions as well as kits
comprising the aforementioned nucleic acid molecules and/or comprising a
nucleic acid molecule which is complementary to such a nucleic acid
molecule. Said compositions and kits may further comprise polypeptides
encoded by the described nucleic acid molecules. Furthermore, antagonists
and inhibitors of the aforesaid polypeptides and/or antibodies
specifically recognizing such polypeptides are described. Also provided
are methods and uses comprising the nucleic acid molecules, vectors,
polypeptides, antibodies and antagonists and inhibitors of the invention
for modulating gene expression In humans and animals. Furthermore,
transgenic plant cells and plants containing the aforementioned nucleic
acid molecules as well as the use of the aforementioned nucleic acid
molecules, polypeptides and/or antagonists/inhibitors in plant cell
culture and plant tissue culture and/or plant breeding are described.
|
|
|
< Assay device
< Animals, cells and methods for production of detectably-labeled antibodies
> Phosphatidylcholine biosynthetic enzymes
> THROMBIN DERIVATIVES AND PROCESS FOR PRODUCING THE SAME, ANHYDROTHROMBIN DERIVATIVES AND PROCESS FOR PRODUCING THE SAME, PLATELET AGGLUTINATION-INDUCING COMPOSITIONS, METHOD OF INDUCING PLATELET AGGLUTINATION, CLINICAL TEST REAGENTS, CLINICAL TEST METHOD, THROMBOSIS INHIBITORS, ADSORBENT AND PROCESS FOR PRODUCING THE SAME
|
~ 00282
|